Dr. Ski Chilton seeks a new, sustainable source of omega-3 polyunsaturated fatty acids and a diagnostic to determine who most needs these omega-3s. Read more.
Wake Forest Institute for Regenerative Medicine’s Shay Soker, PhD, is building a bioengineered, 3-dimensional tumor model that mimics a real tumor for more effective drug development and developmental biology studies. Read more.
To perform a series of life-saving operations on a newborn girl, Adele Evans, M.D., needed a special type of small plastic tube to help the baby breathe. Trouble was, there was no such device. Read more.
Our scientists are developing tomorrow’s innovations in therapeutics, vaccines, medical devices and more. Get updates from Wake Forest Innovations.
Read the May 2015 Open Innovation e-Newsletter to learn more about scientists and discoveries at Wake Forest Baptist Medical Center.
This new device can replace an endotracheal tube efficiently and is ideal for replacing tubes in cases of tube malfunction, inappropriate size or restricted airway tracks.
Listen to this Bio Report Podcast in which Eric Tomlinson, DSc, PhD, discusses our Open Innovation model and lays out a fresh vision for the future of academic and industry partnerships.
Wake Forest Innovations offers an extensive portfolio of technology licensing opportunities in biomedical and materials science.
Wake Forest Innovations supports your R&D needs through easy access to Wake Forest's unique research capabilities.
Wake Forest Innovations drives the creation of a new hub for innovation in biomedical and materials science and information technology.
Postgraduate fellows in maternal-fetal medicine at Wake Forest Baptist Medical Center are now practicing invasive procedures on a training device invented by a Wake Forest Baptist physician and designed and built by Forsyth Technical Community College students in collaboration with Wake Forest Innovations. While the patent-pending device, an ultrasound-guided invasive procedure trainer, was conceived for continue reading
New proof-of-concept research at Wake Forest Institute for Regenerative Medicine suggests the potential for engineering replacement intestine tissue in the lab, a treatment that could be applied to infants born with a short bowel and adults having large pieces of gut removed due to cancer or inflammatory bowel disease. Lead researcher Khalil N Bitar, Ph.D., continue reading